Macro-or microencapsulation of pig islets to cure type 1 diabetes

World Journal of Gastroenterology

Volumn 18, Issue 47, 2012, Pages 6885-6893

  Dufrane, Denis ^a   Gianello, Pierre ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Cell transplantation; Diabetes mellitus type 1; Islets of langerhans; Porcine; Xenografits

Indexed keywords

ALGINIC ACID; BIOTIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INSULIN; MACROGOL; MEMBRANE COFACTOR PROTEIN; POLYLYSINE; POLYORNITHINE; STREPTAVIDIN;

ARTICLE; BIOARTIFICIAL ORGAN; BIOCOMPATIBILITY; CELL INFILTRATION; CELL TRANSPLANTATION; CELL VIABILITY; ENCAPSULATION; GLYCEMIC CONTROL; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MACROENCAPSULATION; MICROENCAPSULATION; NONHUMAN; OXYGEN TENSION; PANCREAS ISLET; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIMATE; SWINE; XENOTRANSPLANTATION;

EID: 84873884189     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i47.6885     Document Type: Article

References (82)

1. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238
2. Frank AM, Barker CF, Markmann JF. Comparison of whole organ pancreas and isolated islet transplantation for type 1 diabetes. Adv Surg 2005; 39: 137-163
3. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060-2069
4. Cooper DK, Gollackner B, Sachs DH. Will the pig solve the transplantation backlog? Annu Rev Med 2002; 53: 133-147
5. First MR. Xenotransplantation: social, ethical, religious, and political issues. Kidney Int Suppl 1997; 58: S46-S47
6. Sachs DH. The pig as a potential xenograft donor. Vet Im-munol Immunopathol 1994; 43: 185-191
7. Kurz H. Physiology of angiogenesis. J Neurooncol 2000; 50: 17-35
8. Mendola JF, Conget I, Manzanares JM, Corominola H, Viñas O, Barcelo J, Gomis R. Follow-up study of the revascularization process of purifed rat islet beta-cell grafts. Cell Transplant 1997; 6: 603-612
9. Menger MD, Jaeger S, Walter P, Feifel G, Hammersen F, Messmer K. Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans. Diabetes 1989; 38 Suppl 1: 199-201
10. Patan S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J Neurooncol 2000; 50: 1-15
11. Vajkoczy P, Menger MD, Simpson E, Messmer K. Angiogenesis and vascularization of murine pancreatic islet isografts. Transplantation 1995; 60: 123-127
12. Vajkoczy P, Olofsson AM, Lehr HA, Leiderer R, Hammersen F, Arfors KE, Menger MD. Histogenesis and ultrastructure of pancreatic islet graft microvasculature. Evidence for graft revascularization by endothelial cells of host origin. Am J Pathol 1995; 146: 1397-1405
13. Korsgren O, Jansson L. Discordant cellular xenografits revascularized in intermediate athymic hosts fail to induce a hyperacute rejection when transplanted to immunocompetent rats. Transplantation 1994; 57: 1408-1411
14. Söderlund J, Wennberg L, Castaños-Velez E, Biberfeld P, Zhu S, Tibell A, Groth CG, Korsgren O. Fetal porcine isletlike cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study. Transplantation 1999; 67: 784-791
15. Kirchhof N, Shibata S, Wijkstrom M, Kulick DM, Salerno CT, Clemmings SM, Heremans Y, Galili U, Sutherland DE, Dalmasso AP, Hering BJ. Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografits precedes acute cellular rejection. Xenotransplantation 2004; 11: 396-407
16. Cantarovich D, Blancho G, Potiron N, Jugeau N, Fiche M, Chagneau C, Letessier E, Boeffard F, Loth P, Karam G, Soulillou JP, Le Mauff B. Rapid failure of pig islet transplantation in non human primates. Xenotransplantation 2002; 9: 25-35
17. Bühler L, Deng S, O'Neil J, Kitamura H, Koulmanda M, Baldi A, Rahier J, Alwayn IP, Appel JZ, Awwad M, Sachs DH, Weir G, Squifflet JP, Cooper DK, Morel P. Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade. Xenotransplantation 2002; 9: 3-13
18. Nishimaki T, Kano K, Milgrom F. Hanganutziu-Deicher antigen and antibody in pathologic sera and tissues. J Immunol 1979; 122: 2314-2318
19. Komoda H, Miyagawa S, Kubo T, Kitano E, Kitamura H, Omori T, Ito T, Matsuda H, Shirakura R. A study of the xenoantigenicity of adult pig islets cells. Xenotransplantation 2004; 11: 237-246
20. Auchincloss H, Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 1998; 16: 433-470
21. Rayat GR, Rajotte RV, Hering BJ, Binette TM, Korbutt GS. In vitro and in vivo expression of Galalpha-(1,3)Gal on porcine islet cells is age dependent. J Endocrinol 2003; 177: 127-135
22. Bennet W, Sundberg B, Lundgren T, Tibell A, Groth CG, Richards A, White DJ, Elgue G, Larsson R, Nilsson B, Korsgren O. Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation 2000; 69: 711-719
23. Dor FJ, Cheng J, Alt A, Cooper DK, Schuurman HJ. Gal alpha 1,3Gal expression on porcine pancreatic islets, testis, spleen, and thymus. Xenotransplantation 2004; 11: 101-106
24. Dufrane D, Goebbels RM, Guiot Y, Gianello P. Is the expression of Gal-alpha1,3Gal on porcine pancreatic islets modifed by isolation procedure? Transplant Proc 2005; 37: 455-457
25. Dufrane D, Goebbels RM, Saliez A, Guiot Y, Gianello P. Sixmonth survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation 2006; 81: 1345-1353
26. Hering BJ, Wijkstrom M, Graham ML, Hårdstedt M, Aasheim TC, Jie T, Ansite JD, Nakano M, Cheng J, Li W, Moran K, Christians U, Finnegan C, Mills CD, Sutherland DE, Bansal-Pakala P, Murtaugh MP, Kirchhof N, Schuurman HJ. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006; 12: 301-303
27. Cardona K, Korbutt GS, Milas Z, Lyon J, Cano J, Jiang W, Bello-Laborn H, Hacquoil B, Strobert E, Gangappa S, Weber CJ, Pearson TC, Rajotte RV, Larsen CP. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006; 12: 304-306
28. O'Connell PJ, Cunningham A, d'Apice AJF. Xenotransplantation: its problems and potential as a clinical procedure. Transplant Rev 2000; 14: 18-40
29. Tran HM, Nickerson PW, Patel A, Strom TB, Allen RDM, O'Connell PJ. Short-term suppression of the xeno-immune response with mCTLA4-Fc treatment. Xenotransplantation 1997; 4: 222-227
30. Yi S, Lehnert M, Davey K, OConnell PJ. T cell activated macrophages are capable of rejecting pancreatic islet xenografits. Xenotransplantation 2001; 8 Suppl s1: 38
31. Rijkelijkhuizen JK, Haanstra KG, Wubben J, Töns A, Roos A, van Gijlswijk-Janssen DJ, Ringers J, Bouwman E, Jonker M. T-cell-specific immunosuppression results in more than 53 days survival of porcine islets of langerhans in the monkey. Transplantation 2003; 76: 1359-1368
32. van der Windt DJ, Bottino R, Casu A, Campanile N, Smetanka C, He J, Murase N, Hara H, Ball S, Loveland BE, Ayares D, Lakkis FG, Cooper DK, Trucco M. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 2009; 9: 2716-2726
33. Thompson P, Badell IR, Lowe M, Cano J, Song M, Leopardi F, Avila J, Ruhil R, Strobert E, Korbutt G, Rayat G, Rajotte R, Iwakoshi N, Larsen CP, Kirk AD. Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function. Am J Transplant 2011; 11: 2593-2602
34. Schuler W, Bigaud M, Brinkmann V, Di Padova F, Geisse S, Gram H, Hungerford V, Kleuser B, Kristofc C, Menninger K, Tees R, Wieczorek G, Wilt C, Wioland C, Zurini M. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation. Transplantation 2004; 77: 717-726
35. de Vos P, Hamel AF, Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 2002; 45: 159-173
36. Algire GH. An adaptation of the transparent-chamber technique to the mouse. J Natl Cancer Inst 1943; 4: 1-11
37. Strautz RL. Studies of hereditary-obese mice (obob) after implantation of pancreatic islets in Millipore flter capsules. Diabetologia 1970; 6: 306-312
38. Rafael E, Wernerson A, Arner P, Wu GS, Tibell A. In vivo evaluation of glucose permeability of an immunoisolation device intended for islet transplantation: a novel application of the microdialysis technique. Cell Transplant 1999; 8: 317-326
39. Elliott RB, Escobar L, Tan PL, Garkavenko O, Calafore R, Basta P, Vasconcellos AV, Emerich DF, Thanos C, Bambra C. Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplant Proc 2005; 37: 3505-3508
40. Elliott RB, Escobar L, Calafore R, Basta G, Garkavenko O, Vasconcellos A, Bambra C. Transplantation of microand macroencapsulated piglet islets into mice and monkeys. Transplant Proc 2005; 37: 466-469
41. Valdés-González RA, Dorantes LM, Garibay GN, BrachoBlanchet E, Mendez AJ, Dávila-Pérez R, Elliott RB, Terán L, White DJ. Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study. Eur J Endocrinol 2005; 153: 419-427
42. Birmingham K. Skepticism surrounds diabetes xenograft experiment. Nat Med 2002; 8: 1047
43. Dufrane D, Goebbels RM, Gianello P. Alginate macroencapsulation of pig islets allows correction of streptozotocininduced diabetes in primates up to 6 months without immunosuppression. Transplantation 2010; 90: 1054-1062
44. Veriter S, Aouassar N, Xhema D, Beaurin G, Adnet PY, Igarashi Y, Gianello P, Dufrane D. CTS-IXA 2011 Joint International CongressParallel Session 5: Islet Xenotransplantation Preclinical Models Islets and mesenchymal stem cells co-encapsulation can improve subcutaneous bioartificial pancreas survival in diabetic primates. Xenotransplantation 2011; 18: 275-278
45. van Schilfgaarde R, de Vos P. Factors infuencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. J Mol Med (Berl) 1999; 77: 199-205
46. Duvivier-Kali VF, Omer A, Lopez-Avalos MD, O'Neil JJ, Weir GC. Survival of microencapsulated adult pig islets in mice in spite of an antibody response. Am J Transplant 2004; 4: 1991-2000
47. Omer A, Duvivier-Kali VF, Trivedi N, Wilmot K, BonnerWeir S, Weir GC. Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes 2003; 52: 69-75
48. Dufrane D, Steenberghe M, Goebbels RM, Saliez A, Guiot Y, Gianello P. The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials 2006; 27: 3201-3208
49. Orive G, Hernández RM, Gascón AR, Calafiore R, Chang TM, De Vos P, Hortelano G, Hunkeler D, Lacík I, Shapiro AM, Pedraz JL. Cell encapsulation: promise and progress. Nat Med 2003; 9: 104-107
50. Contreras JL. Extrahepatic transplant sites for islet xenotransplantation. Xenotransplantation 2008; 15: 99-101
51. Sun Y, Ma X, Zhou D, Vacek I, Sun AM. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografits of microencapsulated porcine islets without immunosuppression. J Clin Invest 1996; 98: 1417-1422
52. Elliott RB, Escobar L, Tan PL, Muzina M, Zwain S, Buchanan C. Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation. Xenotransplantation 2007; 14: 157-161
53. Basta G, Montanucci P, Luca G, Boselli C, Noya G, Barbaro B, Qi M, Kinzer KP, Oberholzer J, Calafiore R. Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases. Diabetes Care 2011; 34: 2406-2409
54. Tuch BE, Keogh GW, Williams LJ, Wu W, Foster JL, Vaithilingam V, Philips R. Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care 2009; 32: 1887-1889
55. Calafore R, Basta G, Luca G, Boselli C, Bufalari A, Bufalari A, Cassarani MP, Giustozzi GM, Brunetti P. Transplantation of pancreatic islets contained in minimal volume microcapsules in diabetic high mammalians. Ann NY Acad Sci 1999; 875: 219-232
56. Miura S, Teramura Y, Iwata H. Encapsulation of islets with ultra-thin polyion complex membrane through poly(ethylene glycol)-phospholipids anchored to cell membrane. Biomaterials 2006; 27: 5828-5835
57. Teramura Y, Kaneda Y, Iwata H. Islet-encapsulation in ultrathin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials 2007; 28: 4818-4825
58. Teramura Y, Iwata H. Islets surface modifcation prevents blood-mediated inflammatory responses. Bioconjug Chem 2008; 19: 1389-1395
59. Teramura Y, Iwata H. Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation. Transplantation 2009; 88: 624-630
60. Contreras JL, Xie D, Mays J, Smyth CA, Eckstein C, Rahemtulla FG, Young CJ, Anthony Thompson J, Bilbao G, Curiel DT, Eckhoff DE. A novel approach to xenotransplantation combining surface engineering and genetic modifcation of isolated adult porcine islets. Surgery 2004; 136: 537-547
61. Lee JY, Choo JE, Choi YS, Park JB, Min DS, Lee SJ, Rhyu HK, Jo IH, Chung CP, Park YJ. Assembly of collagen-binding peptide with collagen as a bioactive scaffold for osteogenesis in vitro and in vivo. Biomaterials 2007; 28: 4257-4267
62. Sefton MV. The good, the bad and the obvious: 1993 Clemson Award for Basic Research--Keynote Lecture. Biomaterials 1993; 14: 1127-1134
63. De Vos P, De Haan BJ, Wolters GH, Strubbe JH, Van Schilfgaarde R. Improved biocompatibility but limited graft survival after purifcation of alginate for microencapsulation of pancreatic islets. Diabetologia 1997; 40: 262-270
64. De Vos P, De Haan B, Van Schilfgaarde R. Effect of the alginate composition on the biocompatibility of alginatepolylysine microcapsules. Biomaterials 1997; 18: 273-278
65. De Vos P, Van Straaten JF, Nieuwenhuizen AG, de Groot M, Ploeg RJ, De Haan BJ, Van Schilfgaarde R. Why do microencapsulated islet grafts fail in the absence of fbrotic overgrowth? Diabetes 1999; 48: 1381-1388
66. Duvivier-Kali VF, Omer A, Parent RJ, O'Neil JJ, Weir GC. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 2001; 50: 1698-1705
67. Soon-Shiong P, Heintz RE, Merideth N, Yao QX, Yao Z, Zheng T, Murphy M, Moloney MK, Schmehl M, Harris M. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994; 343: 950-951
68. Lim F, Sun AM. Microencapsulated islets as bioartifcial endocrine pancreas. Science 1980; 210: 908-910
69. Strand BL, Ryan TL, In't Veld P, Kulseng B, Rokstad AM, Skjak-Brek G, Espevik T. Poly-L-Lysine induces fbrosis on alginate microcapsules via the induction of cytokines. Cell Transplant 2001; 10: 263-275
70. King A, Sandler S, Andersson A. The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J Biomed Mater Res 2001; 57: 374-383
71. Korbutt GS, Mallett AG, Ao Z, Flashner M, Rajotte RV. Improved survival of microencapsulated islets during in vitro culture and enhanced metabolic function following transplantation. Diabetologia 2004; 47: 1810-1818
72. Vériter S, Mergen J, Goebbels RM, Aouassar N, Grégoire C, Jordan B, Levêque P, Gallez B, Gianello P, Dufrane D. In vivo selection of biocompatible alginates for islet encapsulation and subcutaneous transplantation. Tissue Eng Part A 2010; 16: 1503-1513
73. Omer A, Keegan M, Czismadia E, De Vos P, Van Rooijen N, Bonner-Weir S, Weir GC. Macrophage depletion improves survival of porcine neonatal pancreatic cell clusters contained in alginate macrocapsules transplanted into rats. Xenotransplantation 2003; 10: 240-251
74. Safey SA, Kapp LM, Tucker-Burden C, Hering B, Kapp JA, Weber CJ. Inhibition of cellular immune responses to encapsulated porcine islet xenografits by simultaneous blockade of two different costimulatory pathways. Transplantation 2005; 79: 409-418
75. de Vos P, Smedema I, van Goor H, Moes H, van Zanten J, Netters S, de Leij LF, de Haan A, de Haan BJ. Association between macrophage activation and function of microencapsulated rat islets. Diabetologia 2003; 46: 666-673
76. de Groot M, Schuurs TA, Leuvenink HG, van Schilfgaarde R. Macrophage overgrowth affects neighboring nonovergrown encapsulated islets. J Surg Res 2003; 115: 235-241
77. Hall JC, Heel KA, Papadimitriou JM, Platell C. The pathobiology of peritonitis. Gastroenterology 1998; 114: 185-196
78. Hsu BR, Chang FH, Juang JH, Huang YY, Fu SH. The rescue effect of 15-deoxyspergualin on intraperitoneal microencapsulated xenoislets. Cell Transplant 1999; 8: 307-315
79. Pattou F, Kerr-Conte J, Wild D. GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle. N Engl J Med 2010; 363: 1289-1290
80. Espes D, Eriksson O, Lau J, Carlsson PO. Striated muscle as implantation site for transplanted pancreatic islets. J Transplant 2011; 2011: 352043
81. Kriz J, Vilk G, Mazzuca DM, Toleikis PM, Foster PJ, White DJ. A novel technique for the transplantation of pancreatic islets within a vascularized device into the greater omentum to achieve insulin independence. Am J Surg 2012; 203: 793-797
82. Perez VL, Caicedo A, Berman DM, Arrieta E, Abdulreda MH, Rodriguez-Diaz R, Pileggi A, Hernandez E, Dubovy SR, Parel JM, Ricordi C, Kenyon NM, Kenyon NS, Berggren PO. The anterior chamber of the eye as a clinical transplantation site for the treatment of diabetes: a study in a baboon model of diabetes. Diabetologia 2011; 54: 1121-1126